Miravo
Miravo is a Canadian healthcare company that produces therapeutic and natural healthcare products across pain, allergy, neurology, and dermatology indications, operating a portfolio of 65+ brands as the specialty pharmaceutical division of Apotex.
- Company typePrivate
- Founded1983
- HeadquartersMississauga, Canada
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Miravo firmographics
Firmographics- Name
- Miravo
- Legal name
- Searchlight Pharma Inc.
- Website
- https://miravohealthcare.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Miravo is a Canadian healthcare company that produces therapeutic and natural healthcare products across pain, allergy, neurology, and dermatology indications, operating a portfolio of 65+ brands as the specialty pharmaceutical division of Apotex.
- Ownership category
- akta.pro rank
Where Miravo is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Markets served
Miravo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Miravo product offering
Product offeringCore offering
Miravo is a healthcare company that develops, acquires, and commercializes specialty pharmaceutical and natural healthcare products across therapeutic areas including pain, allergy, neurology, and dermatology. The company markets a portfolio of over 65 brands through direct commercial operations in Canada and through strategic partners in international markets.
Differentiator
Problem solved
Functional benefit
Brands
- Commercial Brands: Products marketed by Searchlight Pharma in Canada.
- Partnered Brands
- Pipeline
Products and services
- Commercial Brands Portfolio A portfolio of branded specialty pharmaceutical and healthcare products marketed by Searchlight Pharma in Canada, covering women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets. Targeted at healthcare providers and patients through Canadian distribution.
- Partnered Brands Portfolio A network of strategic partners who have introduced Searchlight Pharma products to patients in new markets across the globe. Focused on global commercialization of specialty pharmaceutical products.
- Pharmaceutical Pipeline Products Innovative pharmaceutical products in development across various therapeutic areas, intended to expand the company's branded specialty pharmaceutical offerings.
Companies that use Miravo
Customer profileIdeal customer profiles2 records
Miravo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Miravo partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
Miravo competitors and assessment
Company assessmentOthers
- Apotex Inc. Miravo's parent company and one of Canada's largest generic, biosimilar, and branded pharmaceutical producers — comparable as the broader enterprise of which Miravo is the specialty pharma division, and a key strategic/operational counterparty.
Direct peers
- Cipher Pharmaceuticals: Canadian specialty pharmaceutical company commercializing branded products in dermatology and other specialty areas — directly comparable in therapeutic focus and commercial scale.
- Verity Pharmaceuticals: Canadian specialty pharma commercializing branded products across women's health, dermatology, and specialty categories — directly comparable therapeutic-area overlap with Miravo.
- Acerus Pharmaceuticals: Canadian specialty pharma commercializing products in men's health, women's health, and specialty therapeutics — comparable niche branded-pharma model and Canadian geographic focus.
- Knight Therapeutics: Canadian specialty pharmaceutical company that commercializes innovative and branded products across multiple therapeutic areas in Canada and select international markets — directly comparable business model to Miravo's branded specialty pharma model.
- HLS Therapeutics: Canadian specialty pharma focused on acquiring and commercializing branded products in CNS, cardiovascular, and specialty categories — closely mirrors Miravo's specialty-brand acquisition and commercialization model.
- Theratechnologies: Canadian specialty biopharma focused on specialty therapeutics with commercial reach in North America and select global markets — comparable branded specialty pharma positioning.
Broad incumbents
- Endo International (Paladin Labs): Global specialty pharma that historically operated Paladin Labs in Canada as a specialty branded distribution platform — directly comparable Canadian specialty pharma distribution and commercialization model.
- Bausch Health: Large Canadian-headquartered specialty pharma with diversified branded portfolios across dermatology, neurology, and women's health — broader and larger-scale competitor operating in several of Miravo's therapeutic areas.
Emerging players
- Glenmark Pharmaceuticals: India-headquartered specialty pharma with branded portfolios in dermatology, respiratory, and pain — comparable in therapeutic focus and emerging-market distribution model relevant to Miravo's partnered-brand strategy.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Miravo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Miravo leadership team
Management profileNumber of profiles
Profiles3 records
Miravo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Miravo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Miravo
What does Miravo do?
Miravo is a healthcare company that develops, acquires, and commercializes specialty pharmaceutical and natural healthcare products across therapeutic areas including pain, allergy, neurology, and dermatology. The company markets a portfolio of over 65 brands through direct commercial operations in Canada and through strategic partners in international markets.
Is Miravo a public or private company?
Miravo is a private company. It is classified as corporate owned and is currently operating.
When was Miravo founded?
Miravo was founded in 1983. It employs 51 to 100 people.
Where is Miravo based?
Miravo is headquartered in Mississauga, Canada, in the North America region.
Who are Miravo's main competitors?
Apotex Inc. is listed as an others. Direct peers are Cipher Pharmaceuticals, Verity Pharmaceuticals, Acerus Pharmaceuticals, Knight Therapeutics, HLS Therapeutics and Theratechnologies. Broad incumbents are Endo International (Paladin Labs) and Bausch Health. Glenmark Pharmaceuticals is listed as an emerging player.
Does Miravo have an API?
No public API is recorded for Miravo.